284 Results

People

  1. Moore
    Moore
  2. Cheung
    Cheung
  3. Kushner
    Kushner
  4. Golde
    Golde
  5. Modak
    Modak
  6. Allison
    Allison
  7. Wolchok
    Wolchok
  8. O'Reilly
    O'Reilly
  9. Slovin
    Slovin
  10. Fong
    Fong

Groups

  1. Department of Medicine (122)
  2. Hematologic Malignancies, Division of (72)
  3. GSK Faculty (71)
  4. Sloan Kettering Institute Faculty (69)
  5. Solid Tumor Oncology Division (54)
  6. Center for Hematologic Malignancies (49)
  7. Pediatrics, Department of (47)
  8. Tow Center for Developmental Oncology (TCDO) (44)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (42)
  10. Center for Molecular Imaging and Biotechnology (31)
  1. "granulocyte macrophage colony stimulating factor"
Formats
  1. Journal Article (265)
  2. Conference Paper (11)
  3. Review (5)
  4. Book Section (1)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (122)
  2. Hematologic Malignancies, Division of (72)
  3. GSK Faculty (71)
  4. Sloan Kettering Institute Faculty (69)
  5. Solid Tumor Oncology Division (54)
  6. Center for Hematologic Malignancies (49)

More Groups

People
  1. Malcolm Moore (29)
  2. Nai-Kong Cheung (25)
  3. Brian Kushner (18)
  4. Jedd Wolchok (18)
  5. David Golde (14)
  6. Shakeel Modak (14)

More People

Years
  1. 2025 (1)
  2. 2024 (9)
  3. 2023 (3)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (1)

More Years

Publications
  1. Blood (23)
  2. Journal of Clinical Oncology (11)
  3. Clinical Cancer Research (9)
  4. Bone Marrow Transplantation (8)
  5. Seminars in Oncology (8)
  6. Cancer (7)

More Publications

Publishers
  1. Elsevier Inc. (28)
  2. Nature Publishing Group (26)
  3. American Society of Hematology (23)
  4. American Association for Cancer Research (17)
  5. Lippincott Williams & Wilkins (17)
  6. Springer (17)

More Publishers

Results (284)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
    Journal Article

    Davar, D.; Carneiro, B. A.; Dy, G. K.; Sheth, S.; Borad, M. J.; Harrington, K. J.; Patel, S. P.; Galanis, E.; Samson, A.; Agrawal, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Omalizumab for treatment of anti-GD2 antibody-related urticaria
    Journal Article

    Glincher, R.; Lentini-Rivera, A.; Jones, L. A.; D'Andrea, L.; Durney, C.; Kasper, C.; Lin, Y.; Shrager, L.; Markova, A.; Lacouture, M.; more...
    Journal of Pediatric Hematology/Oncology (2024)

    Fulltext@MSK | Save
  • Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway
    Journal Article

    Wang, N.; Fang, Y.; Hou, Y.; Cheng, D.; Dressler, E. V.; Wang, H.; Wang, J.; Wang, G.; Li, Y.; Liu, H.; more...
    Cell Communication and Signaling (2024)

    Fulltext@MSK | Save
  • Tuberculosis in otherwise healthy adults with inherited TNF deficiency
    Journal Article

    Arias, A. A.; Neehus, A. L.; Ogishi, M.; Meynier, V.; Krebs, A.; Lazarov, T.; Lee, A. M.; Arango-Franco, C. A.; Yang, R.; Orrego, J.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects
    Journal Article

    Mora, J.; Climent, A.; Roldán, M.; Flores, M. C.; Varo, A.; Perez-Jaume, S.; Jou, C.; Celma, M. S.; Lazaro, J. J.; Cheung, I.; more...
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Radiomodulating properties of superparamagnetic iron oxide nanoparticle (SPION) agent ferumoxytol on human monocytes: Implications for MRI-guided liver radiotherapy
    Journal Article

    Shurin, M. R.; Kirichenko, V. A.; Shurin, G. V.; Lee, D.; Crane, C.; Kirichenko, A. V.
    Cancers (2024)

    Fulltext@MSK | Save
  • Integrative analyses of tumor and peripheral biomarkers in the treatment of advanced renal cell carcinoma
    Journal Article

    Choueiri, T. K.; Donahue, A. C.; Braun, D. A.; Rini, B. I.; Powles, T.; Haanen, J. B. A. G.; Larkin, J.; Mu, X. J.; Pu, J.; Teresi, R. E.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma
    Review

    Mora, J.; Modak, S.; Kinsey, J.; Ragsdale, C. E.; Lazarus, H. M.
    International Journal of Cancer (2024)

    Fulltext@MSK | Save